Andlauer Healthcare Group Inc. (TSX:AND)
Canada
· Delayed Price · Currency is CAD 39.82
-0.43 (-1.07%)
Mar 28, 2025, 4:00 PM EST
Andlauer Healthcare Group Income Statement
Financials in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2016 |
| Revenue | 650.48 | 647.95 | 648.42 | 440.12 | 314.34 | Upgrade
|
| Revenue Growth (YoY) | 0.39% | -0.07% | 47.33% | 40.01% | 8.40% | Upgrade
|
| Cost of Revenue | 432.34 | 432.32 | 425.12 | 287.85 | 209.13 | Upgrade
|
| Gross Profit | 218.14 | 215.63 | 223.3 | 152.26 | 105.21 | Upgrade
|
| Selling, General & Admin | 53.24 | 51.43 | 48.16 | 35.24 | 28.55 | Upgrade
|
| Operating Expenses | 124.18 | 119.58 | 112.61 | 77.96 | 56.57 | Upgrade
|
| Operating Income | 93.96 | 96.05 | 110.69 | 74.3 | 48.64 | Upgrade
|
| Interest Expense | -7.59 | -8.21 | -6.86 | -6.22 | -4.6 | Upgrade
|
| Interest & Investment Income | 2.15 | 3.17 | 0.6 | 0.2 | 0.29 | Upgrade
|
| Earnings From Equity Investments | - | - | - | 2.47 | - | Upgrade
|
| Other Non Operating Income (Expenses) | -0.33 | -0.41 | -0.33 | 0.23 | -0.05 | Upgrade
|
| EBT Excluding Unusual Items | 88.2 | 90.61 | 104.1 | 70.98 | 44.28 | Upgrade
|
| Merger & Restructuring Charges | - | - | -0.35 | -1.81 | -0.07 | Upgrade
|
| Gain (Loss) on Sale of Investments | - | - | - | 37.92 | - | Upgrade
|
| Asset Writedown | - | - | - | 0.14 | - | Upgrade
|
| Other Unusual Items | - | - | - | 1.21 | 2.37 | Upgrade
|
| Pretax Income | 88.2 | 90.61 | 103.76 | 108.44 | 46.58 | Upgrade
|
| Income Tax Expense | 23.73 | 24.47 | 27.48 | 18.49 | 8.87 | Upgrade
|
| Earnings From Continuing Operations | 64.47 | 66.14 | 76.28 | 89.95 | 37.71 | Upgrade
|
| Net Income | 64.47 | 66.14 | 76.28 | 89.95 | 37.71 | Upgrade
|
| Net Income to Common | 64.47 | 66.14 | 76.28 | 89.95 | 37.71 | Upgrade
|
| Net Income Growth | -2.53% | -13.29% | -15.21% | 138.52% | 26.67% | Upgrade
|
| Shares Outstanding (Basic) | 40 | 42 | 42 | 39 | 38 | Upgrade
|
| Shares Outstanding (Diluted) | 41 | 43 | 43 | 40 | 38 | Upgrade
|
| Shares Change (YoY) | -3.90% | -0.30% | 6.70% | 3.94% | 1.87% | Upgrade
|
| EPS (Basic) | 1.60 | 1.58 | 1.82 | 2.30 | 1.00 | Upgrade
|
| EPS (Diluted) | 1.58 | 1.55 | 1.79 | 2.25 | 0.98 | Upgrade
|
| EPS Growth | 1.93% | -13.41% | -20.44% | 129.59% | 24.05% | Upgrade
|
| Free Cash Flow | 106.84 | 80.9 | 111.38 | 76.07 | 46.04 | Upgrade
|
| Free Cash Flow Per Share | 2.61 | 1.90 | 2.61 | 1.90 | 1.20 | Upgrade
|
| Dividend Per Share | 0.420 | 0.340 | 0.260 | 0.200 | 0.199 | Upgrade
|
| Dividend Growth | 23.53% | 30.77% | 30.00% | 0.27% | 1648.12% | Upgrade
|
| Gross Margin | 33.53% | 33.28% | 34.44% | 34.60% | 33.47% | Upgrade
|
| Operating Margin | 14.45% | 14.82% | 17.07% | 16.88% | 15.47% | Upgrade
|
| Profit Margin | 9.91% | 10.21% | 11.76% | 20.44% | 12.00% | Upgrade
|
| Free Cash Flow Margin | 16.43% | 12.48% | 17.18% | 17.28% | 14.65% | Upgrade
|
| EBITDA | 150.01 | 151.69 | 145.65 | 90.38 | 53.61 | Upgrade
|
| EBITDA Margin | 23.06% | 23.41% | 22.46% | 20.54% | 17.05% | Upgrade
|
| D&A For EBITDA | 56.05 | 55.63 | 34.96 | 16.08 | 4.97 | Upgrade
|
| EBIT | 93.96 | 96.05 | 110.69 | 74.3 | 48.64 | Upgrade
|
| EBIT Margin | 14.45% | 14.82% | 17.07% | 16.88% | 15.47% | Upgrade
|
| Effective Tax Rate | 26.91% | 27.00% | 26.49% | 17.05% | 19.03% | Upgrade
|
Updated Feb 26, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.